Regarding HER2, the percentage of HER2‐positive cells increased under hypoxic conditions in all HNSCC cell lines (P = 0.065) (Table 1), especially in intrinsically cetuximab‐resistant HNSCC cell lines (P = 0.024) (Fig. 3A). The gene discussed is ERBB2; the disease is head and neck squamous cell carcinoma.